SinuSys Status
The company raised $6.78 million of Series D venture funding from Altos Health Management, AshHill Biomedical and Emergent Medical Partners on September 04, 2014, putting the company's pre-money valuation at $23.46 million. Life Science Angels and other undisclosed investors also participated in the round.
Add a review